What Is TB-500?

TB-500 is the synthetic form of Thymosin Beta-4 (Tβ4), a 43-amino acid protein naturally present in most human and animal cells. Tβ4 is one of the most abundant intracellular peptides in the body and plays a central role in cytoskeletal organization. TB-500 refers specifically to the active fragment — typically the actin-binding domain — used in research settings.

Mechanism: Actin Sequestration & Cell Migration

Thymosin Beta-4's primary function is sequestering G-actin (globular actin), the monomeric form of actin that polymerizes into the filaments required for cell movement. By regulating the G-actin/F-actin ratio, Tβ4 controls the ability of cells to migrate — which is critical in wound healing, immune response, and tissue regeneration. In injury models, elevated TB-500 levels are associated with faster keratinocyte, endothelial, and satellite cell migration to injury sites.

Systemic vs. Local: Why TB-500 Differs from BPC-157

BPC-157 works predominantly at the site of administration, with effects concentrated in adjacent tissue. TB-500 distributes systemically — the same injection can affect multiple tissue types simultaneously. This makes TB-500 particularly interesting in research models where the injury involves multiple structures (e.g., muscle plus connective tissue) or where a systemic anti-inflammatory effect is part of the research question.

The BPC-157 + TB-500 Stack in Research

The two peptides are frequently used together in research settings because they act through different mechanisms on different timescales. BPC-157 primarily drives angiogenesis and local fibroblast activity; TB-500 drives cellular migration and cytoskeletal reorganization systemically. The combination provides complementary coverage and is sometimes referred to informally as the "Wolverine Stack" in research communities — though no head-to-head combination trial has been published.

COA Verification for TB-500

At 43 amino acids, TB-500 is larger than BPC-157 and requires careful HPLC analysis. Look for purity ≥98% with MS confirmation of the correct molecular weight (~4,963 Da for the full Tβ4 fragment). Because TB-500 is commonly confused with shortened fragments or other thymosin variants, mass spectrometry identity confirmation is non-negotiable. Batch-specific COAs from ISO 17025-accredited labs are the only documentation that should be trusted.